Nutra Pharma Announces First Manufacturing Agreement

Plantation, Florida, March 23, 2022 (GLOBE NEWSWIRE) — Nutra Pharma Corporation (OTC Pink: NPHC), a biotechnology firm advertising Nyloxin®, Pet Pain-Away™, Equine Pain-Away™ and Luxury Feet™ within the over-the-counter (OTC) ache administration market and which can also be growing remedies for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV) and Pain, is saying their first settlement to behave as a product formulator and contract producer for an outdoor firm, Avini Health. “We’ve spent the final two years bringing all of our manufacturing in-house,” said Rik J Deitsch, CEO of Nutra Pharma. “These manufacturing capabilities enable us to provide all of our personal merchandise; but in addition gives the choice to behave as a contract producer for different corporations to doubtlessly present an extra income stream for Nutra Pharma,” he continued. “To that finish, we now have simply signed our first contract with an outdoor firm to offer them with formulation experience, product ideation and manufacturing of completed items. Making these extra merchandise additionally permits us to doubtlessly decrease our personal manufacturing prices as we benefit from economies of scale to buy packaging and uncooked supplies. This relationship has already supplied revenues and we count on this income stream to turn out to be substantial over the following few quarters,” he concluded. Avini Health is a brand new firm constructed on an online marketing mannequin. Their preliminary product choices embody merchandise for detoxing, immune system help in addition to Nutra Pharma’s OTC ache relievers; Nyloxin. “We’re excited to be partnered with Nutra Pharma”, commented Neil Roth, president of Avini Health. “Nutra Pharma has entry to a deep bench of certified scientists and formulators that can present Avini Health with progressive and best-in-class merchandise,” he continued. “To begin, we’ve added Rik Deitsch as our Chief Scientific Officer for his work because the class creator for micronized and activated zeolite; a product that we’re advertising as Cell Defender. As we develop, we consider that Nutra Pharma will be capable to scale up and develop with us to launch extra merchandise in addition to assist us market Nutra Pharma’s unimaginable line of Homeopathic medicine,” he concluded. Nutra Pharma will present additional updates on new merchandise, manufacturing capabilities and contract manufacturing alternatives all through the remainder of 2022. About Avini HealthAvini Health is growing revolutionary holistic merchandise and promoting by way of the Direct Selling phase. The line of nutraceuticals being manufactured for Avini is by far probably the most in depth grouping of science-based vitamin merchandise within the market at the moment. Under the brand “Avini Health,” these merchandise shall be each proprietary and distinctive based mostly on Zeolite and nano know-how. These merchandise shall be directed in the direction of mobile well being and immune system capabilities. Created by biotechnology professionals, Avini Health’s broad number of merchandise create a path to wellness by way of pure, non-addictive components. For extra details about Avini Health, go to: https://avinihealth.com About Nutra Pharma Corp. Nutra Pharma Corporation operates as a biotechnology firm specializing within the acquisition, licensing, and commercialization of pharmaceutical merchandise and applied sciences for the administration of neurological issues, most cancers, autoimmune, and infectious ailments, together with Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV) and Pain. Additionally, the Company markets drug merchandise on the market for the therapy of ache underneath the model Nyloxin®, Equine Pain-Away™, Luxury Feet™ and Pet Pain-Away™. For extra details about Nutra Pharma, go to: http://www.NutraPharma.com orhttp://www.nyloxin.comhttp://www.petpainaway.comhttp://www.equinepainaway.comhttp://www.luxuryfeet.com SEC Disclaimer This press launch incorporates forward-looking statements. The phrases or phrases “could be,” “will enable,” “intends to,” “will doubtless outcome,” “are anticipated to,” “will proceed,” “is anticipated,” “estimate,” “challenge,” or comparable expressions are meant to determine “forward-looking statements.” Actual outcomes might differ materially from these projected in Nutra Pharma’s (“the Company”) marketing strategy. The manufacturing settlement with Avini Health shouldn’t be construed as a sign in any approach in any respect of the longer term worth of the Company’s frequent inventory or its monetary worth. The Company’s filings could also be accessed on the SEC’s Edgar system at www.sec.gov.  Statements made herein are as of the date of this press launch and shouldn’t be relied upon as of any subsequent date. The Company cautions readers to not place reliance on such statements. Unless in any other case required by relevant legislation, we don’t undertake, and we particularly disclaim any obligation, to replace any forward-looking statements to mirror occurrences, developments, unanticipated occasions or circumstances after the date of such assertion.

https://www.globenewswire.com/news-release/2022/03/23/2408664/0/en/Nutra-Pharma-Announces-First-Manufacturing-Agreement.html

Recommended For You